Edwards Lifesciences
EW
#516
Rank
S$53.65 B
Marketcap
$90.97
Share price
2.42%
Change (1 day)
0.10%
Change (1 year)
Categories

P/E ratio for Edwards Lifesciences (EW)

P/E ratio as of November 2024 (TTM): 28.6

According to Edwards Lifesciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 28.5787. At the end of 2022 the company had a P/E ratio of 30.5.

P/E ratio history for Edwards Lifesciences from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202230.5-43.11%
202153.5-22.54%
202069.149.02%
201946.44.16%
201844.516.54%
201738.28.87%
201635.11.98%
201534.4106.95%
201416.6-11.75%
201318.8-46.71%
201235.43.53%
201134.2-18.88%
201042.197.31%
200921.3-10.29%
200823.81.9%
200723.310.18%
200621.2-32.27%
200531.3-96.97%
2004> 10004495.59%
200322.4-18.04%
200227.4-117.84%
2001-153

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
105 268.39%๐Ÿ‡บ๐Ÿ‡ธ USA
58.6 104.88%๐Ÿ‡บ๐Ÿ‡ธ USA
82.1 187.27%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
32.1 12.25%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-83.4-391.84%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.